13F Pro Quality Score

12.3/100

Rank #2,888 of 2,962 stocks

View Healthcare peers →

Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Nov 14, 2026.

Email me the moment this company reports earnings
AI Research Report
Two-page plain-English analysis: business, thesis, and three scenarios for the next two years. Refreshed every quarter.
Upgrade to Pro
Pro: 5 reports/month · Pro+: unlimitedOpinion, not investment advice. Do your own research.

VERU Stock Analysis & AI Quality Score

Data updated 2026-09-11

AI stock analysis and institutional research for VERU INC. (VERU), a Healthcare sector company. 13F Pro's AI-powered ranking engine scores VERU at 12.3/100 on a 32-signal composite quality model, placing it at rank #2,888 of 2,962 stocks — the bottom half of the AI-ranked universe. Based on the latest XBRL financial filings (Q2 2026), VERU INC. reports net income of $-7.0M, free cash flow of $-5.5M. Top institutional holders of VERU by reported 13-F value include VANGUARD CAPITAL MANAGEMENT, Alyeska Investment Group, L.P., OPPENHEIMER, based on the most recent SEC filings. VERU trades on the Nasdaq exchange and files with the SEC under CIK 863894. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate VERU daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for VERU INC. directly from SEC EDGAR. VERU INC.'s 13F Pro composite quality score has ranged between 6 and 54 since 2021, currently 12.3 — a declining long-term trajectory across 21 quarterly and live scoring snapshots.

Net Income

Q2 2026

$-7.0M

Free Cash Flow

Q2 2026

$-5.5M

Period

Revenue & Net Income

Earnings Per Share

Key Financials Over Time

Export Financial Table · Pro

Revenue

FY 2025
FY22 $39.4MFY23 $16.3MFY24 $16.9MFY25

Net Income

+39.9% YoY
$-22.7MFY 2025
FY22 $-84.0MFY23 $-93.2MFY24 $-37.8MFY25 $-22.7M

Operating Income

+31.6% YoY
$-24.8MFY 2025
FY22 $-83.5MFY23 $-93.8MFY24 $-36.2MFY25 $-24.8M

EPS (Diluted)

FY 2025
FY22 $-1.05FY23 $-1.10FY24 FY25

Total Assets

-50.6% YoY
$29.8MFY 2025
FY22 $135.4MFY23 $50.0MFY24 $60.4MFY25 $29.8M

Op. Cash Flow

-38.6% YoY
$-30.0MFY 2025
FY22 $-47.5MFY23 $-88.0MFY24 $-21.7MFY25 $-30.0M

Free Cash Flow

-37.6% YoY
$-30.0MFY 2025
FY22 $-48.2MFY23 $-88.7MFY24 $-21.8MFY25 $-30.0M

Get alerted when VERU's score changes

Free account: watchlist tracking, the daily AI brief, and the AI screener.

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Available Research

13F Pro tracks comprehensive data for VERU INC. including:

SEC EDGAR filings (10-K, 10-Q, 8-K)
XBRL financial facts (revenue, EPS, margins)
Insider transactions (Form 4)
Institutional 13F holdings
Quality rankings (32 signals)
AI analyst debates & daily meetings
Historical financial trends
Peer comparison & sector analysis

Top Institutional Holders of VERU

Put VERU on your watchlist

Track score changes the day VERU INC. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.

View Pricing

Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Is VERU a good stock to buy?

13F Pro's AI-powered analysis of VERU INC. (VERU) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for VERU are available on the VERU stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing. VERU is classified as a small company.

Which hedge funds own VERU?

Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling VERU. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of VERU INC.'s investment landscape.